 WES MOORE, Governor  Ch. 714  
 
– 1 – Chapter 714  
(House Bill 553 ) 
 
AN ACT concerning  
 
Maryland Medical Assistance Program – Maternal Health  Self–Measured Blood 
Pressure Monitoring  
 
FOR the purpose of requiring, beginning on a certain date, the Maryland Medical 
Assistance Program to provide coverage for self –measured blood pressure 
monitoring for certain eligible Program recipients; requiring the Program to develop 
and implement a cer tain education campaign;  and generally relating to  
self–measured blood pressure monitoring under the Maryland Medical Assistance 
Program.  
 
BY repealing and reenacting, without amendments,  
 Article – Health – General  
Section 15 –101(h), (j), and (l) and 15–103(a)(1)  
 Annotated Code of Maryland  
 (2023 Replacement Volume and 2024 Supplement)  
 
BY repealing and reenacting, with amendments,  
 Article – Health – General  
Section 15 –103(a)(2)(xxiii) and (xxiv)  
 Annotated Code of Maryland  
 (2023 Replacement Volume and 2024 Supplement)  
 
BY adding to  
 Article – Health – General  
Section 15 –103(a)(2)(xxv) and 15 –141.6  
 Annotated Code of Maryland  
 (2023 Replacement Volume and 2024 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Health – General  
 
15–101. 
 
 (h) “Program” means the Maryland Medical Assistance Program.  
 
 (j) “Self –measured blood pressure monitoring” means the regular measurement 
of blood pressure by the patient outside the clinical setting, either at home or elsewhere, 
requiring the use of a home blood pressure measurement device by the patient.  
 
Ch. 714  2025 LAWS OF MARYLAND   
 
– 2 –  (l) “Validated home blood pressure monitor” means a blood pressure 
measurement device that has been validated for accuracy and is  listed in the U.S. Blood 
Pressure Validated Device Listing.  
 
15–103. 
 
 (a) (1) The Secretary shall administer the Maryland Medical Assistance 
Program.  
 
  (2) The Program:  
 
   (xxiii)  Beginning on July 1, 2025, shall provide, subject to the 
limitations of the State budget, and as permitted by federal law, coverage for biomarker 
testing in accordance with § 15 –859 of the Insurance Article; [and] 
 
   (xxiv)  Beginning on January 1, 2025, shall provide coverage for 
prostheses in accordance with § 15 –844 of the Insurance Article ; AND  
 
   (XXV) BEGINNING ON JANUARY 1, 2026,  SHALL PROVIDE , 
SUBJECT TO THE LIMIT ATIONS OF THE STATE BUDGET , AND AS PERMITTED BY 
FEDERAL LAW , COVERAGE FOR SELF –MEASURED BLOOD PRESS URE MONITORING 
FOR ELIGIBLE PROGRAM RECIPIENTS IN  ACCORDANC E WITH § 15–141.6  OF THIS 
SUBTITLE . 
 
15–141.6.  
 
 (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS  
INDICATED . 
 
  (2) “ELIGIBLE PROGRAM , “ELIGIBLE PROGRAM  RECIPIENT ” MEANS 
A PROGRAM RECIPIENT WHO : 
 
   (I) (1)  IS PREGNANT ; 
 
   (II) (2) IS POSTPARTUM ; OR 
 
   (III) (3) HAS BEEN DIAGNOSED WI TH: 
 
    1. (I) CHRONIC KIDNEY DISEAS E; 
 
    2. (II) DIABETES ; 
 
    3. (III) HEART DISEASE ; OR 
 
 WES MOORE, Governor  Ch. 714  
 
– 3 –     4. (IV) A CARDIOMETABOLIC DISE ASE. 
 
  (3) “HEALTH CARE PROVIDER ” MEANS : 
 
   (I) A PERSON WHO IS LICENS ED, CERTIFIED , OR OTHERWISE  
AUTHORIZED UNDER THE  HEALTH OCCUPATIONS ARTICLE TO PROVIDE HE ALTH  
CARE IN THE ORDINARY  COURSE OF BUSINESS O R PRACTICE OF A PROF ESSION , OR 
IN AN APPROVED EDUCA TION OR TRAINING PRO GRAM ; OR 
 
   (II) A COMMUNITY HEALTH WOR KER CERTIFIED UNDER TITLE  
13, SUBTITLE 37 OF THIS ARTICLE . 
 
 (B) THE PROGRAM SHALL PROVIDE  COVERAGE FOR SELF –MEASURED 
BLOOD PRESSURE MONIT ORING FOR ALL ELIGIB LE PROGRAM RECIPIENTS , 
INCLUDING : 
 
  (1) THE PROVISION OF VALI DATED HOME BLOOD PRE SSURE 
MONITORS ; AND 
 
  (2) REIMBURSEMENT OF HEALTH  CARE PROVIDER AND OT HER STAFF 
TIME USED FOR PATIEN T TRAINING , TRANSMISSION OF BLOO D PRESSURE DATA , 
INTERPRETATION OF BL OOD PRESSURE READING S AND REPORTING , REMOTE 
PATIENT MONITORING , AND THE DELIVERY OF CO–INTERVENTIONS , INCLUDING 
EDUC ATIONAL MATERIALS OR  CLASSES . 
 
 (C) THE PROGRAM SHALL DEVELOP  AND IMPLEMENT AN EDU CATION  
CAMPAIGN TO INFORM E LIGIBLE PROGRAM RECIPIENTS AN D HEALTH CARE  
PROVIDERS ABOUT THE BENEFITS AND USAGE O F BLOOD PRESSURE MON ITORING  
TECHNOLOGY AND THE A VAILABILITY OF A SSISTANCE WITH SETUP  AND  
TROUBLESHOOTING . 
 
 (D) ON OR BEFORE DECEMBER 1 EACH YEAR , BEGINNING IN 2027,  THE 
DEPARTMENT SHALL SUBM IT A REPORT TO THE SENATE FINANCE COMMITTEE AND  
THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE , IN 
ACCORDANCE WITH § 2–1257  OF THE STATE GOVERNMENT ARTICLE , THAT  
INCLUDES : 
 
  (1) THE TOTAL NUMBER OF E LIGIBLE PROGRAM RECIPIENTS WH O 
RECEIVED BLOOD PRESS URE MONITORS UNDER T HIS SECTION DURING T HE 
IMMEDIATELY PRECEDIN G 12–MONTH PERIOD ; 
 
  (2) THE OUTCOMES ASSOCIAT ED WITH THE USE OF  THE HOME BLOOD  
PRESSURE MONITORS UN DER THIS SECTION ; AND  
 
Ch. 714  2025 LAWS OF MARYLAND   
 
– 4 –   (3) ANY COST SAVINGS ACHI EVED BY THE PROGRAM DURING THE  
IMMEDIATELY PRECEDIN G FISCAL YEAR ASSOCI ATED WITH THE USE OF  THE HOME  
BLOOD PRESSURE MONIT ORS DISTRIBUTED IN A CCORDANCE WITH THIS SECTION . 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 
1, 2025.  
 
Approved by the Governor, May 20, 2025.  